News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
VENLO, The Netherlands, July 23 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that its offer to exchange cash and stock for all outstanding shares of Digene Corporation (Nasdaq: DIGE) expired as scheduled at 11:59 p.m., New York City time, on Friday, July 20, 2007. All conditions of the exchange offer... Read more
CHALFONT ST. GILES, UK – 9 November 2015 – Technetium-99m (Tc‑99m) is used in more than 40 million medical imaging procedures each year, primarily stress tests to assess heart disease, and bone scans to determine the stage of cancer progression. This essential medical isotope is generated in pharmacies and hospitals from another isotope—molybdenum-99 (Mo-99). Despite... Read more
MENLO PARK, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a pioneer and leader in long-read sequencing using Single Molecule, Real-Time (SMRT®) Technology, today announced that its technology will be featured in 36 presentations at next week’s American Society of Human Genetics (ASHG) 2015 annual meeting taking place in Baltimore,... Read more
Sequel™ System Offers Significantly Higher Throughput, Reducing Project Costs and TimelinesMENLO PARK, Calif., Sept. 30, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) Technology, today announced it has launched a new nucleic acid sequencing platform. The Sequel™ System provides higher... Read more
MENLO PARK, Calif., July 13, 2015 (GLOBE NEWSWIRE) — A number of new scientific publications demonstrate the growing momentum for using Single Molecule, Real-Time (SMRT®) Sequencing to capture genetic variants that other technologies miss, according to Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System. This has been demonstrated through... Read more
MENLO PARK, Calif., May 4, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that BGI, the world’s largest genomics organization, has purchased its first PacBio RS II instrument and plans to purchase additional units in order to integrate Single Molecule, Real-Time (SMRT®) Sequencing... Read more
MENLO PARK, Calif., April 27, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced the introduction of several new solutions for targeted sequencing applications.The company has introduced a new workflow that combines Roche NimbleGen’s SeqCap EZ enrichment technology with large DNA fragments (up to... Read more
MENLO PARK, Calif., March 23, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that the company has launched a Certified Service Provider (CSP) program and added new informatics partners to meet the increasing demand for Single Molecule, Real-Time (SMRT®) Sequencing and data analysis... Read more
–Philibert will focus on cultivating a culture of innovation and excellence for 10x Genomics employees worldwide– PLEASANTON, CA.—June 14, 2018—10x Genomics, a company focused on accelerating genomic discovery, today announced that Jean Philibert has joined the company as Chief People Officer. She brings almost 20 years experience in leading human resources for companies in software... Read more
Financial solutions meet today and tomorrow’s changing requirements Expanded relationship with Caradigm to address population health needs ORLANDO, FLORIDA — February 24, 2014 — GE Healthcare today announced new offerings from its $2B software investment targeting the rapidly emerging market for integrated care solutions. These new offerings combine software, services and a broad ecosystem of... Read more